Phase 1 PARKINSON DISEASE (Disorder) Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease

Serina Therapeutics40 enrolled6 locationsNCT07422675

Recruiting

Phase 1Phase 2

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

SafetyPARKINSON DISEASE (Disorder)Apathy

Integrative Research Laboratories AB75 enrolled13 locationsNCT07461220

Recruiting

Phase 1Phase 2

Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

PARKINSON DISEASE (Disorder)

U: The Mind Company30 enrolled1 locationNCT07182058